1. Durvalumab in NSCLC: latest evidence and clinical potential. (October 2018) Authors: Muñoz-Unceta, Nerea; Burgueño, Isabel; Jiménez, Elizabeth; Paz-Ares, Luis Journal: Therapeutic advances in medical oncology Issue: Volume 10(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. High risk of thrombosis in patients with advanced lung cancer harboring rearrangements in ROS1. (December 2020) Authors: Muñoz-Unceta, Nerea; Zugazagoitia, Jon; Manzano, Arancha; Jiménez-Aguilar, Elisabeth; Olmedo, María E.; Cacho, Juan D.; Oliveira, Julio; Dómine, Manuel; Ortega-Morán, Laura; Aguado, Carlos; Luna, Ana M.; Fernández, Lourdes; Pérez, Javier; Font, Carme; Salvador, Carmen; Corral, Jesús; Benítez, Gre... Journal: European journal of cancer Issue: Volume 141(2020) Page Start: 193 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Perioperative trastuzumab, capecitabine and oxaliplatin in patients with HER2-positive resectable gastric or gastro-oesophageal junction adenocarcinoma: NEOHX phase II trial. (March 2021) Authors: Rivera, Fernando; Izquierdo-Manuel, Marta; García-Alfonso, Pilar; Martínez de Castro, Eva; Gallego, Javier; Limón, María Luisa; Alsina, María; López, Luis; Galán, Maica; Falcó, Esther; Manzano, José Luis; González, Encarna; Muñoz-Unceta, Nerea; López, Carlos; Aranda, Enrique; Fernández, Eva; Jorg... Journal: European journal of cancer Issue: Volume 145(2021) Page Start: 158 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗